Differential requirement of Rab22a for the recruitment of ER-derived proteins to phagosomes and endosomes in dendritic cells.


Journal

Small GTPases
ISSN: 2154-1256
Titre abrégé: Small GTPases
Pays: United States
ID NLM: 101530974

Informations de publication

Date de publication:
05 2020
Historique:
pubmed: 30 9 2017
medline: 17 7 2021
entrez: 30 9 2017
Statut: ppublish

Résumé

The recruitment of endoplasmic reticulum (ER) components to dendritic cell (DC) phagosomes and endosomes is a crucial event to achieve efficient cross-presentation of exogenous antigens. We have previously identified the small GTPase Rab22a as a key regulator of MHC-I trafficking and antigen cross-presentation by DCs. In this study we show that low expression of Rab22a does not prevent the normal delivery of ER-derived proteins to DC phagosomes. In contrast, the presence of these proteins was diminished in endosomes labelled with a fluid phase marker. These observations were confirmed by a functional assay that assesses the translocation of a soluble protein to the cytosol. Interestingly, we also demonstrate that early endosomal maturation is altered in Rab22a deficient DCs. Our results indicate that Rab22a plays a major role in endosomal function and highlight the importance of studying the endocytic and phagocytic pathways separately in DCs.

Identifiants

pubmed: 28960134
doi: 10.1080/21541248.2017.1384088
pmc: PMC7549639
doi:

Substances chimiques

Membrane Transport Proteins 0
RAB22A protein, human 0
rab GTP-Binding Proteins EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

211-219

Références

Science. 2009 Jul 10;325(5937):213-7
pubmed: 19498108
Traffic. 2008 Sep;9(9):1446-57
pubmed: 18564371
Microsc Microanal. 2005 Apr;11(2):166-74
pubmed: 15817146
Cell Microbiol. 2015 Sep;17(9):1365-75
pubmed: 25801707
Bioarchitecture. 2013 Sep-Dec;3(5):141-6
pubmed: 24284901
J Cell Biol. 2006 Sep 25;174(7):923-9
pubmed: 16982798
Nat Immunol. 2007 Aug;8(8):873-81
pubmed: 17603487
Cell. 2006 Mar 24;124(6):1283-98
pubmed: 16564017
EMBO J. 2015 Jul 14;34(14):1848-58
pubmed: 26041457
Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3029-34
pubmed: 18272486
Nat Rev Mol Cell Biol. 2009 Apr;10(4):287-92
pubmed: 19277045
Nature. 2002 Oct 3;419(6906):480-3
pubmed: 12368856
Mol Cell Biol. 2006 Apr;26(7):2595-614
pubmed: 16537905
Cell. 2014 Jul 31;158(3):506-21
pubmed: 25083866
Nat Rev Immunol. 2012 Jul 13;12(8):557-69
pubmed: 22790179
Cell Microbiol. 2010 Sep 1;12(9):1292-307
pubmed: 20345488
Cell. 2011 Dec 9;147(6):1355-68
pubmed: 22153078
Immunol Rev. 2007 Oct;219:143-56
pubmed: 17850487
Science. 2003 Feb 28;299(5611):1400-3
pubmed: 12610307
Eur J Immunol. 2017 Jul;47(7):1160-1170
pubmed: 28508576
J Cell Sci. 2001 Nov;114(Pt 22):4041-9
pubmed: 11739636
Nat Cell Biol. 2014 May;16(5):434-44
pubmed: 24705552
Immunol Rev. 2016 Jul;272(1):80-96
pubmed: 27319344
Science. 1996 Apr 12;272(5259):263-7
pubmed: 8602510
Mol Biol Cell. 2004 Aug;15(8):3758-70
pubmed: 15181155
Immunity. 2009 Apr 17;30(4):544-55
pubmed: 19328020
J Cell Sci. 2017 Jul 15;130(14):2405-2415
pubmed: 28584192
Nature. 2003 Sep 25;425(6956):397-402
pubmed: 14508489
J Exp Med. 2009 Feb 16;206(2):399-410
pubmed: 19153244
Cell Rep. 2015 Sep 22;12(11):1816-30
pubmed: 26344766
Cell. 2006 Jul 14;126(1):205-18
pubmed: 16839887
EMBO Rep. 2016 Dec;17(12):1753-1765
pubmed: 27861124
Biochim Biophys Acta. 2015 Jun;1851(6):805-23
pubmed: 25238964
Annu Rev Immunol. 2017 Apr 26;35:149-176
pubmed: 28125356

Auteurs

Cristina Croce (C)

Instituto de Histología y Embriología de Mendoza (IHEM, Universidad Nacional de Cuyo, CONICET), Facultad de Ciencias Médicas, Mendoza, Argentina.

Luis S Mayorga (LS)

Instituto de Histología y Embriología de Mendoza (IHEM, Universidad Nacional de Cuyo, CONICET), Facultad de Ciencias Médicas, Mendoza, Argentina.

Ignacio Cebrian (I)

Instituto de Histología y Embriología de Mendoza (IHEM, Universidad Nacional de Cuyo, CONICET), Facultad de Ciencias Médicas, Mendoza, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH